Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.000
-0.040 (-3.85%)
At close: Dec 20, 2024, 4:00 PM
1.020
+0.020 (2.00%)
After-hours: Dec 20, 2024, 6:37 PM EST
Immunic Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Immunic stock have an average target of 12.67, with a low estimate of 5.00 and a high estimate of 28. The average target predicts an increase of 1,167.00% from the current stock price of 1.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Immunic stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 3 | 3 | 4 | 4 |
| Buy | 2 | 2 | 3 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 6 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +900.00% | Nov 25, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +1,600.00% | Nov 7, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +1,600.00% | Oct 22, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +1,600.00% | Sep 18, 2024 |
| EF Hutton | EF Hutton | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +1,600.00% | Sep 16, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.01
from -2.11
EPS Next Year
-0.73
from -1.01
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | |||
| Avg | n/a | n/a | n/a | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.02 | -0.42 | -0.33 | |||
| Avg | -1.01 | -0.73 | -0.66 | |||
| Low | -1.00 | -0.87 | -0.91 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.